Through activation of the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway, CNTN-1 promotes cisplatin resistance in cisplatin-resistant lung cancer cells and resistant cells. Here, AKT1 is linked to lung carcinoma.